OpenVSafe by OpenVAERS
Search V-safe

KKU-23008-34605

3 vaccinations 1 coded response 26 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
983 / WA
Registered
2020-12-18
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Nausea
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  12. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  13. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  14. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-01-29
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-05
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-11
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-09-29
    Dose 3 — Pfizer-BioNTech
  20. 2021-09-29
    Health check-in — day 0, dose 3
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  21. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Adult check-in
  22. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  23. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  24. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-06
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2021-10-13
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-10-20
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-10-27
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-11-11
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  30. 2022-10-01
    Survey response — 12 months, dose 3
    MedDRA: Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: See below
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-10-01
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  32. 2022-10-05
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-08Pfizer-BioNTech
32021-09-29Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 12 — 12 months, dose 3

2022-10-01

Symptoms: See below

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…